With over 25 years of design experience, Michael Smaldone has held creative leadership roles at Banana Republic, Elie Tahari, Anne Klein, Ann Taylor and Talbots. It is through the learnings at these great American brands that he honed his skills not only as a designer but as a creative brand leader.
Throughout his career, Michael spent many years touring back and forth to Italy where he studied under a master tailor and later built relationships with factories and mills where they opened up their archives and back rooms to him. It is during these years that he found his passion for the craftsmanship of fine tailoring and his love and respect for the finest fabrics. As his career progressed, Michael naturally became involved with creative direction where he was able to stay true to the design of his collections by guiding the creative process from concept through to the customer’s experience by telling one cohesive story that strengthened each brand’s ethos.
His quiet yet powerful passion for form and craftsmanship along with his extensive brand executive training with top American brands has allowed Michael to beautifully balance art and commerce and to truly understand his customer’s needs and desires. Along with dressing countless number of women over the years, Michael has also had the privilege of dressing celebrities such as Julianne Moore, Brooke Shields, Katie Couric, Kathie-Lee Gifford, Maria Sharapova to name a few, as well as First Lady Michelle Obama.
In 2010 Michael had the honor of being accepted into The Council of Fashion Designers of America (CFDA) whose membership consists of more than 400 of America’s foremost womenswear, menswear, jewelry and accessory designers and where he dedicates his time to the education and fostering of young and upcoming talent.
Since 2008, Michael and his husband James have been staunch supporters of and are proud to be part of the amfAR family, which is one of the world’s leading non-profit organizations dedicated to the support of AIDS research, and which has pledged to have the disease eradicated by the year 2020.